Vivanza Biosciences Ltd.
Snapshot View

189.00 ▼0%

16 May 2022, 04:00:00 PM

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website https://www.vivanzabiosciences.com/
Market Cap 75.60 Cr.
Enterprise Value(EV) 78.53 Cr. 2021-09
Financial Indicators
Earnings per share (EPS) 1.01 Trailing Twelve Months Ending 2021-12
Price-Earning Ratio (PE) 187.13 Trailing Twelve Months Ending 2021-12
Industry PE 114.81 Trailing Twelve Months Ending 2021-12
Book Value / Share 9.23 Trailing Twelve Months Ending 2021-12
Price to Book Value 20.48 Calculated using Price: 189.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.40 Cr. 4,000,000 Shares
FaceValue 10
Company Profile

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

  • Gloves
  • Surgicals

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
1 Month
+1.07%
3 Month
+23.57%
6 Month
-0.29%
1 Year
+165.64%
2 Year
+1342.75%
5 Year
+7.54%
10 Year
6 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -242.60 -17.54 5.66 -12.56 -6.46 2.41
Return on Capital Employed (%) -11.38 -10.82 12.73 -0.40 5.74 17.11
Return on Assets (%) -9.49 -7.99 2.37 -4.15 -1.75 0.72

Balance Sheet View Details

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-09* Rs. Cr.
Shh. Funds 0 4 4 3 3 3 4
Non Curr. Liab. 0 1 1 0 3
Curr. Liab. 1 3 6 7 9 5 3
Minority Int.
Equity & Liab. 1 7 10 11 12 8 10
Non Curr. Assets 1 3 3 3 3 3 3
Curr. Assets 0 4 7 8 9 5 7
Misc. Exp. not W/O
Total Assets 1 7 10 11 12 8 10

Profit Loss View Details

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-12 Rs. Cr. TTM
Net Sales 3 6 3 10 10 7
Other Income 0 1 1 1
Total Income 4 6 3 10 10 8
Total Expenditure 0 -4 -6 -3 -10 -10 -8
PBIDT 0 0 1 0 0 1 1
Interest 0 0 0 0 0 0
Depreciation 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0 0 0 0 0
Adjusted EPS -3 -1 1 -1 -1 0 1

Cash Flow View Details

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -2 0 1 3 -3
Cash Fr. Inv. 2 0
Cash Fr. Finan. 0 -1 -1 -3 2
Net Change 0 -1 0 0 0
Cash & Cash Eqvt -2 -3 -3 -3 -3

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 47.80 47.80 47.80 47.80 47.80 47.80 47.80 47.80 47.80
Public 52.20 52.20 52.20 52.20 52.20 52.20 52.20 52.20 52.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 18 May 2022
Board Meeting Intimation for Board Meeting Intimation For Notice Of Board Meeting Pursuant To Regulation 29(1) Of SEBI LODR Regulations 2015
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve 1) To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter ended 31st March 2022 ;2) To consider Preferential Issue of Warrants.3) To Increase the Authorised Share Capital of the Company from Rs. 4.00 Crore to Rs. 9.00 Crore.4) To change the Clause V- Authorised Capital of Memorandum of Association (MOA) of the Company;5) To consider the Termination of existing Company Secretary and to Appoint the new Company Secretary and Compliance Officer of the Company.6) To invest in the Vitaanova Healthcare Uganda Limited a Company incorporated in Uganda. 7) To Appoint the Statutory Auditor of the Company. 8) To consider and approve the notice of Annual General Meeting to seek approval for the above mentioned items as recommended by the Board.9) Any other business as Board deem fit to discuss with the permission of the Chair.
Sat, 30 Apr 2022
Compliance Certificate By PCS For Half Year Ended 31/03/2022
Compliance Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the half year ended on 31st March 2022.
Fri, 29 Apr 2022
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Vivanza Biosciences Ltd
2 CIN NO. L24110GJ1982PLC005057
3 Report filed for FY 2022-2023
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* NA
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)NA
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Mr Jainil Bhatt
Designation :-Chief Financial Officer
Name of the Chief Financial Officer :- Mr Jainil Bhatt
Designation : -Chief Financial Officer

Date: 29/04/2022

Technical Scans View Details

No Scans Found

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 236,561.63 2,075.10 -4.0%
Redington (India) Ltd. 10,561.39 135.15 -2.6%
MMTC Ltd. 5,805.00 38.70 -2.9%
Optiemus Infracom Ltd. 2,371.48 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. 1,732.47 51.60 -5.0%
SIRCA Paints India Ltd. 1,141.67 416.60 -3.8%
Shree Global Tradefin Ltd. 954.09 7.50 -4.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 304.63 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2022-03 8.25 135.15 -2.6%
MMTC Ltd. Consolidated 2021-12 0.00 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-12 23.91 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-12 0.00 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-12 31.06 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-12 0.00 7.50 -4.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 7.90 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2022-03 1.83 135.15 -2.6%
MMTC Ltd. Consolidated 2021-12 -20.25 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-12 7.26 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-12 10.77 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-12 5.12 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-12 1.48 7.50 -4.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2021-03 0.09 135.15 -2.6%
MMTC Ltd. Consolidated 2021-03 24.24 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-03 0.31 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.10 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 0.07 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 0.01 7.50 -4.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2021-03 17.02 135.15 -2.6%
MMTC Ltd. Consolidated 2021-03 -160.71 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.07 7.50 -4.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2021-03 17.02 135.15 -2.6%
MMTC Ltd. Consolidated 2021-03 -160.71 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.07 7.50 -4.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 135.15 -2.6%
MMTC Ltd. Consolidated 2021-03 30,001.47 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-03 314.39 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 32.11 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 143.18 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 0.80 7.50 -4.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 2,075.10 -4.0%
Redington (India) Ltd. Consolidated 2021-03 786.61 135.15 -2.6%
MMTC Ltd. Consolidated 2021-03 -790.07 38.70 -2.9%
Optiemus Infracom Ltd. Consolidated 2021-03 86.50 276.35 -4.4%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.33 51.60 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 16.58 416.60 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.24 7.50 -4.5%